Plasma YKL-40 and total and disease-specific mortality in the general population

Julia S Johansen; Stig E Bojesen; Anne Tybjaerg-Hansen; Anne K Mylin; Paul A Price; Børge G Nordestgaard

doi:10.1373/clinchem.2010.146530

Plasma YKL-40 and total and disease-specific mortality in the general population

Julia S Johansen, Stig E Bojesen, Anne Tybjaerg-Hansen, Anne K Mylin, Paul A Price, Børge G Nordestgaard

52 Citations (Scopus)

Abstract

Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.

Original language	English
Journal	Clinical Chemistry (Washington, DC)
Volume	56
Issue number	10
Pages (from-to)	1580-91
Number of pages	12
ISSN	0009-9147
DOIs	https://doi.org/10.1373/clinchem.2010.146530
Publication status	Published - 1 Oct 2010

Access to Document

10.1373/clinchem.2010.146530

Cite this

@article{a65f567b8380438492bc638d6cf57f0e,

title = "Plasma YKL-40 and total and disease-specific mortality in the general population",

abstract = "Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.",

author = "Johansen, {Julia S} and Bojesen, {Stig E} and Anne Tybjaerg-Hansen and Mylin, {Anne K} and Price, {Paul A} and Nordestgaard, {B{\o}rge G}",

year = "2010",

month = oct,

day = "1",

doi = "10.1373/clinchem.2010.146530",

language = "English",

volume = "56",

pages = "1580--91",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry, Inc",

number = "10",

}

TY - JOUR

T1 - Plasma YKL-40 and total and disease-specific mortality in the general population

AU - Johansen, Julia S

AU - Bojesen, Stig E

AU - Tybjaerg-Hansen, Anne

AU - Mylin, Anne K

AU - Price, Paul A

AU - Nordestgaard, Børge G

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.

AB - Increased plasma YKL-40 is associated with short-term survival in patients with cardiovascular disease and cancer. We tested the hypothesis that increased plasma YKL-40 is associated with total and disease-specific mortality in the general population.

U2 - 10.1373/clinchem.2010.146530

DO - 10.1373/clinchem.2010.146530

M3 - Journal article

C2 - 20798353

VL - 56

SP - 1580

EP - 1591

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 10

ER -

Plasma YKL-40 and total and disease-specific mortality in the general population

Abstract

Access to Document

Fingerprint

Cite this